- Home
- Advocacy
- Latest News and Practice Data
- Connecticut genetic privacy law enacted after CAP, state advocacy
On May 27, Gov. Ned Lamont signed Senate Bill 4, establishing new genetic privacy rules for direct-to-consumer testing companies.
The CAP and the Connecticut Society of Pathologists (CSP) previously secured an amendment to the bill to ensure it would not apply to clinicians ordering genetic tests for medical purposes.
The impact: Due to the CAP-backed amendment, the law’s genetic privacy and consent requirements do not apply to:
• Any individual licensed in Connecticut to provide health care services.
• Any such individual acting within their scope of practice to order genetic testing for a medical purpose.
Because of CAP and CSP advocacy, Connecticut pathologists are shielded from additional consent requirements and related liability when ordering medically necessary genetic tests.
What's next: The law takes effect October 1, 2026.
Go deeper: Read the prior article on this legislation.